← Open Payments lookup

JINAL PATEL: Open Payments

NPI 1710464110 · GLASSBORO, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,020 in 54 payments from 11 companies in 2025. Trend: 2023 $752 · 2024 $896 · 2025 $1,020

Food & beverage: $915Education: $104
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.12$229
Teva Pharmaceuticals USA, Inc.6$177
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$162
Lundbeck LLC10$144
E.R. Squibb & Sons, L.L.C.5$83
Alkermes, Inc.4$67
Axsome Therapeutics, Inc.3$54
ABBVIE INC.3$49
Neurocrine BioSciences, Inc.1$20
Vanda Pharmaceuticals Inc.1$17

Products named: REXULTI, CAPLYTA, ABILIFY ASIMTUFII, AUSTEDO XR, COBENFY, Auvelity, VRAYLAR, ARISTADA.

Industry payments across NJ — which companies pay providers there.